Diagnostic performance of APRI and FIB-4 for confirming cirrhosis in Indonesian HIV/HCV co-infected patients

BACKGROUND: After successful of antiretroviral therapy, highly effective direct acting antiviral (DAA) make HCV elimination reasonable in HIV/HCV co-infected patients. However, in achieving this target, there are still barriers to start DAA treatment, particularly in the area of liver fibrosis asses...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:BMC Infect Dis
Egile Nagusiak: Yunihastuti, Evy, Wicaksana, Bramantya, Wiraguna, Andrian, Hidayah, Ainum Jhariah, Amelia, Fhadilla, Natali, Veritea, Widhani, Alvina, Sulaiman, Andri Sanityoso, Kurniawan, Juferdy
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2020
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7249442/
https://ncbi.nlm.nih.gov/pubmed/32450844
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-020-05069-5
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak